Amid heightened global trade tensions and significant market volatility, the recent announcement of higher-than-expected tariffs by the U.S. has led to a sharp decline in stock indices worldwide, with small-cap stocks particularly affected as evidenced by the Russell 2000's notable drop. In such uncertain times, identifying high growth tech stocks can be crucial for investors looking for opportunities that may offer resilience and potential upside despite broader economic challenges.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Shanghai Baosight SoftwareLtd | 21.43% | 27.67% | ★★★★★★ |
eWeLLLtd | 24.66% | 25.31% | ★★★★★★ |
Shanghai Huace Navigation Technology | 26.94% | 24.31% | ★★★★★★ |
Pharma Mar | 24.24% | 40.82% | ★★★★★★ |
Seojin SystemLtd | 31.68% | 39.34% | ★★★★★★ |
Ascelia Pharma | 46.09% | 66.93% | ★★★★★★ |
CD Projekt | 33.68% | 36.76% | ★★★★★★ |
Arabian Contracting Services | 21.29% | 30.65% | ★★★★★★ |
Elliptic Laboratories | 49.76% | 88.21% | ★★★★★★ |
JNTC | 34.26% | 86.00% | ★★★★★★ |
Click here to see the full list of 773 stocks from our Global High Growth Tech and AI Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: ROBOTIS Co., Ltd. is a South Korean company that specializes in providing robotic solutions, with a market capitalization of ₩394.16 billion.
Operations: ROBOTIS Co., Ltd. generates revenue primarily from developing, manufacturing, and selling personal robots, contributing ₩30.04 billion to its financial performance.
ROBOTIS, despite its current unprofitability, is poised for significant growth with revenue expected to increase by 40.6% annually, outpacing the Korean market's average of 7.2%. This robust expansion is complemented by an anticipated earnings surge of 113.23% per year. The company's recent Annual General Meeting highlighted strategic plans that could further enhance these figures. Moreover, ROBOTIS maintains a positive free cash flow, reinforcing its financial stability amidst aggressive expansion efforts in the tech sector. While challenges remain due to its low forecasted Return on Equity at 3.4%, the firm’s trajectory towards profitability within three years and its performance exceeding market averages underscore a potentially bright future in high-growth tech sectors.
Explore historical data to track ROBOTIS' performance over time in our Past section.
Simply Wall St Growth Rating: ★★★★★☆
Overview: EuBiologics Co., Ltd. is a biopharmaceutical company specializing in providing vaccines for epidemics in South Korea, with a market cap of ₩384 billion.
Operations: EuBiologics generates revenue primarily from its pharmaceuticals segment, amounting to approximately ₩69.37 billion. The company focuses on developing and distributing vaccines tailored for epidemic outbreaks within the South Korean market.
EuBiologics, set to become profitable within three years, is navigating the high-growth tech landscape with a notable 25.1% revenue increase over the past year, significantly outpacing the Korean market's average growth of 7.2%. This surge is underpinned by an aggressive R&D strategy, crucial for staying competitive in biotechnology. Despite current unprofitability, earnings are projected to climb by 66.33% annually. The company's strategic focus was evident at its recent Annual General Meeting in March 2025, where future plans were outlined to bolster these growth figures further.
Evaluate EuBiologics' historical performance by accessing our past performance report.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Nayax Ltd. is a fintech company that provides comprehensive solutions for automated self-service retailers and merchants across multiple regions, with a market cap of ₪4.63 billion.
Operations: The company generates revenue primarily from its Internet Software and Services segment, amounting to $314.01 million.
Nayax has demonstrated robust growth potential, with a 19.1% annual revenue increase and an expected leap into profitability within three years, showcasing its adaptability in the tech sector. This growth is supported by strategic partnerships, like the recent one with N-and Group to integrate payment technologies into smart screens for automated commerce, highlighting Nayax's commitment to innovation and market expansion. Furthermore, the company's focus on embedded payment solutions for electric vehicle charging stations aligns with evolving consumer needs and broadens its market reach. With R&D expenditures strategically channeled towards these innovative ventures, Nayax is not just keeping pace but setting trends in its industry segments.
Learn about Nayax's historical performance.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A108490 KOSDAQ:A206650 and TASE:NYAX.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.